TrialInvestigational new drugs2013

Multicenter phase II study of everolimus in patients with metastatic or recurrent bone and soft-tissue sarcomas after failure of anthracycline and ifosfamide.

Changhoon Yoo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.